Amarin Corp Plcuk (AMRN) Deferred Taxes (2013 - 2016)
Amarin Corp Plcuk (AMRN) posted quarterly Deferred Taxes of $11.9 million for Q4 2016, up 546.89% YoY from $1.8 million in Q1 2016, and up 1026.4% sequentially from -$1.3 million in Q3 2016.
Amarin Corp Plcuk (AMRN) Deferred Taxes (2013 - 2016) Analysis & Trends
Amarin Corp Plcuk has disclosed Deferred Taxes across 4 years of filings, most recently posting $11.9 million for Q4 2016.
- In Q4 2016, Deferred Taxes rose 546.89% year-over-year to $11.9 million; the TTM figure through Dec 2016 stood at $8.8 million (up 306.91% YoY), while the FY2019 annual figure was $1.8 million, up 190.29% from the prior year.
- Deferred Taxes climbed to $11.9 million in Q4 2016, from -$1.3 million in the prior quarter.
- Over the last five years, Deferred Taxes for AMRN reached as high as $11.9 million in Q4 2016 and fell as low as -$3.9 million in Q1 2013.
- The 4-year median for Deferred Taxes is -$743500.0 (2015), against an average of -$200500.0.
- Annual changes were most pronounced in 2015 — Deferred Taxes tumbled 2151.61% — and 2016, when it soared 546.89%.
- A 4-year view of Deferred Taxes shows it stood at $2.3 million in 2013, then slumped by 262.26% to -$3.8 million in 2014, then advanced by 29.2% to -$2.7 million in 2015, then soared by 546.89% to $11.9 million in 2016.
- According to Business Quant data, Deferred Taxes over the past three periods registered $11.9 million, -$1.3 million, and -$1.4 million for Q4 2016, Q3 2016, and Q2 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.48 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 159.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 137.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -315.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | -176.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 179.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | -12.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 11.93 Mn |
| Sep 30, 2016 | -1.29 Mn |
| Jun 30, 2016 | -1.40 Mn |
| Mar 31, 2016 | -446,000.00 |
| Dec 31, 2015 | -2.67 Mn |
| Sep 30, 2015 | -851,000.00 |
| Jun 30, 2015 | -636,000.00 |
| Mar 31, 2015 | -95,000.00 |
| Dec 31, 2014 | -3.77 Mn |
| Sep 30, 2014 | 75,000.00 |
| Jun 30, 2014 | 31,000.00 |
| Mar 31, 2014 | -24,000.00 |
| Dec 31, 2013 | 2.32 Mn |
| Sep 30, 2013 | -1.55 Mn |
| Jun 30, 2013 | -887,000.00 |
| Mar 31, 2013 | -3.95 Mn |